|
SAFETY
& CLINICAL DEVELOPMENT
Clinical & Experimental Medicine |
 |
|
|
| |
CLINICAL
TRIALS: EXPERIENCE AT CDRI, LUCKNOW |
| |
Compound |
|
...Final
Outcome |
| |
Centimizone
(Anti-thyroid) |
|
Licensed for marketing |
| |
Centbucridine
(Local anaesthetic) |
|
Licensed for marketing |
| |
Centbutindole
(Neuroleptic) |
|
Licensed for marketing |
| |
Gugulipid
(Hypolipidaemic) |
|
Licensed for marketing |
| |
Centchroman
(Oral contraceptive and DUB) |
|
Licensed for marketing |
| |
Centchroman
(Anti-cancer (Breast) |
|
Phase III |
| |
Centpropazine
(Anti-depressant) |
|
Licensed for marketing |
| |
Chandonium
Iodide (Neuromuscular blocker) |
|
Licensed for marketing |
| |
Consap (Spermicidal
cream) |
|
Licensed for marketing |
| |
Arteether
ab (Anti-malarial) |
|
Licensed for marketing Pediatric
trials NDA submitted |
| |
Compound
80/53 (Anti-malarial) |
|
Licensed for marketing |
| |
Mefloquine
(Anti-malarial) |
|
Phase I studies completed |
| |
Fansimef
(Anti-malarial) |
|
Phase I/II studies completed |
| |
Picroliv
(Hepatoprotective) |
|
Phase III trials completed |
| |
Compound
80/574 (Hypolipidaemic) |
|
Extended Phase III |
| |
M. habana
vaccine (Anti Leprosy) |
|
Phase I/II completed |
| |
CT-1 (Anti-diabetic)
|
|
Phase II completed |
| |
Curcumin
(Anti-inflammatory) |
|
Phase II |
| |
Centperazine
(Anti-filarial) |
|
Phase II |
| |
Centazolone
(Tranquilosedative) |
|
Phase II dropped |
| |
Garlic spray
(Hypolipidaemic) |
|
Phase II dropped |
| |
Compound
73/602 (Anti-allergic) |
|
Phase II - dropped |
| |
Compound
81/470 (Anti-helminthic) |
|
Phase II- dropped |
| |
Centpiperalone
(Hypoglycaemic) |
|
Phase I dropped |
| |
Centhaquine
(Anti-hypertensive)
|
|
Phase I dropped |
| |
Centhaquine
(Oral) |
|
Phase I |
| |
Centhaquine
(Injectable) |
|
dropped |
| |
Coleonol
(Anti-hypertensive) |
|
Phase I dropped |
| |
Cholera
vaccine |
|
Phase I dropped |
| |
Centbutindole
-Injectable (Neuroleptic) |
|
Phase I- dropped |
| |
Rifampicin-
Injectable (Anti-tubercular) |
|
Phase I- dropped |
| |
Compound
82/437 (Anti-filarial) |
|
Phase I - dropped |
| |
Bacosides
A&B (Nootropic) |
|
Phase I completed |
| |
CDRI34-D123
(Anti-diabetic) |
|
Phase I completed |
| |
Comp.99/373
(Anti-osteoporotic) |
|
Phase I to be initiated |
| |
Comp. 97/78
(Anti-malarial) |
|
Phase I in progress |
| |
CDR 134-F194
(Anti-diabetic) |
|
IND submitted |
| |
Comp. 99/411
(Anti-malarial) |
|
IND to be filed |
| |
Herbal medicament
(Anti-stroke) |
|
IND to be filed |
| |
Cu-1/ 002
(PFO) (Hypolipidaemic) |
|
IND to be filed. |
| |
| Team
members |
|
|
|
| |
| |